TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Indivior PLC (OTC: INVVY) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • Investors who purchased shares of Shares of Indivior PLC (OTC: INVVY), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Indivior PLC
Security
OTC: INVVY

Summary

An investigation on behalf of investors of Indivior PLC (OTC: INVVY) shares over potential securities laws violations by Indivior PLC and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Indivior PLC (OTC: INVVY) concerning whether a series of statements by Indivior PLC regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. Indivior PLC reported that its annual Total Revenue declined from over $1.09 billion in 2017 to over $1.005 billion in 2018 and that its Net Income increased from $58 million in 2017 to $275 million in 2018.

Shares of Indivior PLC (OTC: INVVY) declined from $33.67 per share in June 2018 to as low as $1.975 per share on April 10, 2019.

Start Monitoring Your Investments